Nexthera Capital as of Dec. 31, 2017
Portfolio Holdings for Nexthera Capital
Nexthera Capital holds 38 positions in its portfolio as reported in the December 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| SPDR S&P Biotech (XBI) | 31.3 | $170M | 2.0M | 84.87 | |
| Allergan | 6.3 | $34M | 208k | 163.58 | |
| Shire | 4.6 | $25M | 162k | 155.12 | |
| BioMarin Pharmaceutical (BMRN) | 4.4 | $24M | 268k | 89.17 | |
| Mylan Nv | 3.7 | $20M | 470k | 42.31 | |
| Merck & Co (MRK) | 3.6 | $20M | 346k | 56.27 | |
| Bristol Myers Squibb (BMY) | 3.3 | $18M | 296k | 61.28 | |
| AstraZeneca (AZN) | 3.0 | $16M | 467k | 34.70 | |
| Ablynx Nv | 2.9 | $16M | 638k | 24.99 | |
| Clovis Oncology | 2.9 | $16M | 233k | 68.00 | |
| Insmed (INSM) | 2.9 | $16M | 499k | 31.18 | |
| Dova Pharmaceuticals | 2.4 | $13M | 453k | 28.80 | |
| Global Blood Therapeutics In | 2.3 | $12M | 312k | 39.35 | |
| Flexion Therapeutics | 2.1 | $12M | 467k | 25.04 | |
| Sangamo Biosciences (SGMO) | 2.1 | $12M | 709k | 16.40 | |
| Alnylam Pharmaceuticals (ALNY) | 2.0 | $11M | 86k | 127.06 | |
| Fibrogen (FGEN) | 1.8 | $9.5M | 201k | 47.40 | |
| Sage Therapeutics (SAGE) | 1.7 | $9.2M | 56k | 164.70 | |
| Sucampo Pharmaceuticals | 1.7 | $9.2M | 511k | 17.95 | |
| Alexion Pharmaceuticals | 1.6 | $8.7M | 72k | 119.59 | |
| Glycomimetics (GLYC) | 1.5 | $8.1M | 480k | 16.79 | |
| Marinus Pharmaceuticals | 1.4 | $7.6M | 925k | 8.16 | |
| Kura Oncology (KURA) | 1.3 | $6.8M | 446k | 15.30 | |
| Immunomedics | 1.2 | $6.5M | 405k | 16.16 | |
| Atara Biotherapeutics | 1.0 | $5.2M | 287k | 18.10 | |
| Spectrum Pharmaceuticals | 0.9 | $4.9M | 259k | 18.95 | |
| Cymabay Therapeutics | 0.9 | $4.9M | 537k | 9.20 | |
| Catalyst Biosciences | 0.8 | $4.2M | 311k | 13.64 | |
| Tesaro | 0.8 | $4.1M | 50k | 82.88 | |
| Flamel Technologies Sa | 0.8 | $4.1M | 506k | 8.20 | |
| Cytomx Therapeutics (CTMX) | 0.7 | $3.8M | 180k | 21.11 | |
| Otonomy | 0.6 | $3.3M | 603k | 5.55 | |
| Therapeuticsmd | 0.6 | $3.2M | 528k | 6.04 | |
| Biosante Pharmaceuticals (ANIP) | 0.5 | $2.7M | 42k | 64.46 | |
| Kalvista Pharmaceuticals (KALV) | 0.3 | $1.8M | 181k | 9.75 | |
| Zafgen | 0.1 | $792k | 171k | 4.62 | |
| Tg Therapeutics (TGTX) | 0.1 | $246k | 30k | 8.20 | |
| Vistagen Therapeutics | 0.0 | $153k | 138k | 1.11 |
